Dobrowsky W
Department of Radiotherapy and Radiobiology, University of Vienna, Austria.
Br J Radiol. 1989 Jan;62(733):53-8. doi: 10.1259/0007-1285-62-733-53.
Forty-eight patients with anal canal cancers were treated with surgery and irradiation or irradiation alone during the period 1970-1982. All cases were treated by external megavoltage equipment. The overall 5-year survival was 50%, and the local recurrence rate 33%. According to the therapy, four major groups were analysed: radical surgery followed by post-operative irradiation (5-year survival 43%, local recurrence rate 38%), incomplete major surgery and post-operative irradiation with very inferior prognosis (none of the patients surviving beyond 52 months). Two groups of patients had sphincter-saving procedures: local surgery followed by irradiation (5-year survival 78%, local recurrence rate 22%) and primary irradiation (5-year survival 57%, local recurrence rate 14%). Lymph node positive patients showed a median survival of 24.5 months against 52 months in N0 cases (5-year survival 21% against 50%). Side-effects of radiotherapy were transient and mild, and no late severe sequelae were seen. The data indicate that post-operative external radiotherapy seems insufficient and unable to decrease the local recurrence rate, especially when surgery is incomplete. Both spincter-saving surgery and radiotherapy, as well as primary irradiation, are effective treatment modalities. These data are analysed and future aspects considering combined radiochemotherapy are discussed.
1970年至1982年期间,48例肛管癌患者接受了手术和放疗或单纯放疗。所有病例均采用体外兆伏级设备治疗。5年总生存率为50%,局部复发率为33%。根据治疗方法,分析了四大组:根治性手术后行术后放疗(5年生存率43%,局部复发率38%),不完全性大手术及术后放疗,预后极差(无一例患者存活超过52个月)。两组患者接受了保留括约肌手术:局部手术后放疗(5年生存率78%,局部复发率22%)和单纯放疗(5年生存率57%,局部复发率14%)。淋巴结阳性患者的中位生存期为24.5个月,而N0病例为52个月(5年生存率分别为21%和50%)。放疗的副作用短暂且轻微,未观察到晚期严重后遗症。数据表明,术后体外放疗似乎不足,无法降低局部复发率,尤其是手术不完全时。保留括约肌手术和放疗以及单纯放疗都是有效的治疗方式。对这些数据进行了分析,并讨论了考虑联合放化疗的未来方向。